Bayer May Face Canadian Class Action Over Trasylol

Law360, New York (December 4, 2008, 12:00 AM EST) -- Already facing dozens of suits in the U.S. over Trasylol, Bayer AG has now been hit with a proposed class action in Canada over the blood-clotting drug, which some studies have indicated can cause potentially fatal side effects.

On Thursday, Ontario-based law firm Siskinds LLP revealed that it had launched a proposed class action earlier in the week, accusing Bayer of withholding knowledge of Trasylol's potential side effects from consumers.

"We believe that through this lawsuit Bayer will be required to explain to Canadian consumers what...
To view the full article, register now.